Trials / Conditions / Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
3 registered clinical trials studyying Atezolizumab and Bevacizumab in Hepatocellular Carcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hep NCT07495735 | First Affiliated Hospital of Wenzhou Medical University | — |
| Enrolling By Invitation | Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain NCT07088081 | Ain Shams University | — |
| Completed | Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for H NCT06416683 | University Hospital, Caen | — |